TY  - GEN
AU  - Wilson,E C F
AU  - Jayne,D R W
AU  - Dellow,E
AU  - Fordham,R J
TI  - The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis
SN  - 1462-0324
PY  - 2007///0917
KW  - Acute Disease
KW  - Computer Simulation
KW  - Cost-Benefit Analysis
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Day Care, Medical
KW  - economics
KW  - Drug Costs
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infusions, Intravenous
KW  - Lupus Erythematosus, Systemic
KW  - drug therapy
KW  - Lupus Nephritis
KW  - Models, Economic
KW  - Mycophenolic Acid
KW  - analogs & derivatives
KW  - Prednisolone
KW  - Quality-Adjusted Life Years
KW  - State Medicine
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/rheumatology/kem054
ER  -